Eczema, Psoriasis and Atopic Dermatitis are allergic skin conditions, which are thought be caused by improper activation of immune system. Skin microbiome of people suffering from allergic skin conditions is dramatically different from healthy people skin.
EnbiomeTherapeutics believes that the skin microbiome produces compounds that keep our skin immune response under check. We have identified a normal human skin microbe that could correct the improper activation of immune system. We are evaluating the therapeutic potential of a cream-based on this skin microbe for allergic skin conditions. In addition, we are conducting screens to identify key microbe or microbial consortium that could be used to treat allergic skin conditions.